Please login to the form below

Not currently logged in
Email:
Password:

lecanemab

This page shows the latest lecanemab news and features for those working in and with pharma, biotech and healthcare.

Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease

Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease

The absolute bioavailability of lecanemab following a single SC injection was 49.7%. ... SC dose to a body weight-based 10mg/kg IV bi-weekly dose with regard to lecanemab exposure.

Latest news

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...